文献速递流行病学与生物统计临床试验与 GCP

儿童青少年高血压筛查:美国预防服务工作组更新证据报告与系统综述

Screening for Hypertension in Children and Adolescents: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
PubMed 文献 · JAMA · 2020-01-01

观察性研究显示儿童期高血压与成年期血压异常相关,但无研究评价筛查获益与危害,血压测量诊断准确性证据不足。药物及生活方式干预可降低儿童血压。

要点

  • 观察性研究提示儿童期高血压与成年期高血压相关,但无直接证据表明筛查或治疗可改善成年结局。
  • 2次诊室血压测量的灵敏度为0.82、特异度为0.70,但证据不足以支持在基层筛查无症状儿童。
  • ACEI和ARB可显著降低儿童收缩压,运动、DASH饮食及药物联合生活方式干预亦有效。

核心结论

  • 观察性研究提示儿童期高血压与成年期高血压相关。
  • 诊断准确性证据不足以判断血压测量是否适合在基层筛查无症状儿童青少年。
  • 无研究评价筛查或治疗儿童高血压对成年结局的获益与危害。

研究设计与样本

  • 纳入诊断准确性研究、队列研究及药物和生活方式干预的随机对照试验(RCT)或荟萃分析,证据定性合成。

主要发现

  • 一项研究报道2次诊室血压测量的灵敏度为0.82、特异度为0.70。
  • 20项观察性研究提示儿童期高血压与成年期血压异常显著相关(OR 1.1-4.5;RR 1.45-3.60;HR 2.8-3.2)。
  • ACEI汇总SBP降低-4.38 mm Hg(95%CI -7.27至-2.16),ARB降低-3.07 mm Hg(95%CI -4.99至-1.44)。
  • 坎地沙坦降低SBP -6.56 mm Hg(P<.001;n=240);β受体阻滞剂、钙通道阻滞剂和盐皮质激素受体拮抗剂在2至4周内未达显著降低。

关键数值与推荐

  • 运动8个月显著降低SBP -4.9 mm Hg(P≤.05;n=69)。
  • DASH饮食3个月降低SBP -2.2 mm Hg(P<.01;n=57)。
  • 药物治疗联合生活方式干预6个月降低SBP -7.6 mm Hg(P<.001;n=95)。
  • 低盐饮食未显著降低血压。

临床怎么用

  • 儿童青少年高血压与成年高血压相关,应关注血压轨迹。
  • 药物干预可降低儿童血压,ACEI和ARB有汇总证据支持。
  • 生活方式干预(运动、DASH饮食)可辅助降低血压。
  • 基层筛查无症状儿童青少年的证据尚不充分,需个体化评估。

局限性

  • 无研究直接评价筛查或治疗儿童高血压对成年结局的获益与危害。
  • 诊断准确性证据有限,仅一项研究报道灵敏度和特异度。
  • 药物试验多为短期、安慰剂对照,缺乏长期结局数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Childhood hypertension can result in adverse outcomes during adulthood; identifying and treating primary and secondary childhood hypertension may reduce such risks. OBJECTIVE: To update the evidence on screening and treatment of hypertension in childhood and adolescence for the US Preventive Services Task Force. DATA SOURCES: PubMed, Cochrane Library, International Pharmaceutical Abstracts, EMBASE, and trial registries through September 3, 2019; bibliographies from retrieved articles, experts, and surveillance of the literature through October 6, 2020. STUDY SELECTION: Fair- or good-quality English-language studies evaluating diagnostic accuracy of blood pressure screening; cohort studies assessing the association of hypertension in childhood and adolescence with blood pressure or other intermediate outcomes in adulthood; randomized clinical trials (RCTs) or meta-analyses of pharmacological and lifestyle interventions. DATA EXTRACTION AND SYNTHESIS: Two reviewers independently assessed titles/abstracts and full-text articles, extracted data, and assessed study quality; the evidence was synthesized qualitatively. MAIN OUTCOMES AND MEASURES: Sensitivity, specificity, and measures of association between childhood and adulthood blood pressure; reduction of childhood blood pressure; adverse effects of treatments. RESULTS: Forty-two studies from 43 publications were included (N>12 400). No studies evaluated the benefits or harms of screening and the effect of treating childhood hypertension on outcomes in adulthood. One study reported a sensitivity of 0.82 and a specificity of 0.70 for 2 office-based blood pressure measurements. Twenty observational studies suggested a significant association between childhood hypertension and abnormal blood pressure in adulthood (odds ratios, 1.1-4.5; risk ratios, 1.45-3.60; hazard ratios, 2.8-3.2). Thirteen placebo-controlled RCTs and 1 meta-analysis assessed reductions in systolic (SBP) and diastolic blood pressure from pharmacological treatments. Pooled reductions of SBP were -4.38 mm Hg (95% CI, -7.27 to -2.16) for angiotensin-converting enzyme inhibitors and -3.07 mm Hg (95% CI, -4.99 to -1.44) for angiotensin receptor blockers. Candesartan reduced SBP by -6.56 mm Hg (P < .001; n = 240). β-Blockers, calcium channel blockers, and mineralocorticoid receptor antagonists did not achieve significant reductions over 2 to 4 weeks. SBP was significantly reduced by exercise over 8 months (-4.9 mm Hg, P ≤ .05; n = 69), by dietary approaches to stop hypertension over 3 months (-2.2 mm Hg, P < .01; n = 57), and by a combination of drug treatment and lifestyle interventions over 6 months (-7.6 mm Hg; P < .001; n = 95). Low-salt diet did not achieve reductions of blood pressure. CONCLUSIONS AND RELEVANCE: Observational studies indicate an association between hypertension in childhood and hypertension in adulthood. However, the evidence is inconclusive whether the diagnostic accuracy of blood pressure measurements is adequate for screening asymptomatic children and adolescents in primary care.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Gartlehner G, Vander Schaaf EB, Orr C, et al. Screening for Hypertension in Children and Adolescents: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2020. PMID: 33170247. doi:10.1001/jama.2020.11119

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。